Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Crispr QC
AddedFeb 15, 2024
UpdatedJun 18, 2026
Crispr QC

Crispr QC

Series A

CRISPR Analytics Platform: Accelerating product development with unique gene editing analytics.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize gene editing, Crispr QC provides an advanced analytics platform that enhances the data and insights available for CRISPR gene editing. Their core product, the CRISPR-Chip, uniquely measures CRISPR activity directly, enabling partners to accelerate product development. Focused on precision and innovation, Crispr QC aims to be a pivotal partner in shaping the future of gene editing.

Notable figures affiliated with Crispr QC include leading scientists and industry experts in biotechnology. The company has garnered significant attention from investors interested in cutting-edge genetic technologies. Key achievements include the successful deployment of their CRISPR-Chip in various research and development projects, significantly reducing time-to-market for new gene editing products. Crispr QC's impact lies in its ability to provide real-time biophysical insights, thus optimizing gene editing processes and contributing to advancements in medical and scientific research.

Crispr QC - Similar Companies

Mammoth Biosciences logo

Mammoth Biosciences

Probius logo

Probius

probius.bio

Tome Biosciences logo

Tome Biosciences

tome.bio

Inscripta logo

Inscripta

inscripta.com

Epic-Bio logo

Epic-Bio

epic-bio.com

Omix.ai logo

Omix.ai

Polarisqb logo

Polarisqb

polarisqb.com

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Quiver Bioscience logo

Quiver Bioscience

Sapient logo

Sapient

sapient.bio

Circular Genomics logo

Circular Genomics

Cradle Genomics logo

Cradle Genomics

Modulari-T logo

Modulari-T

modularit.bio

Caspr logo

Caspr

OmicsCraft logo

OmicsCraft

omicscraft.com

Crispr QC - Quick Facts

Who are Crispr QC's competitors?

Companies similar to Crispr QC include Mammoth Biosciences, Probius, Tome Biosciences and Inscripta.

When was Crispr QC founded?

Crispr QC was founded in 2021.

Where is Crispr QC's headquarters located?

Crispr QC's headquarters is located in San Diego, CA, US.

When was Crispr QC's last funding round?

Crispr QC's most recent funding round was for $10M (USD) in January 2024.

How much has Crispr QC raised to-date?

As of Jan 4, 2024, Crispr QC has raised a total of $11.6M (USD).

How many employees does Crispr QC have?

Crispr QC has 30 employees as of Feb 4, 2024.

Crispr QC - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Analytics Platform
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software